Justin Kim analyst OPPENHEIMER

Covered Stocks

Justin Kim

Work

Analyst Justin Kim works at OPPENHEIMER and is focused on the Healthcare sector with 66 price targets and ratings documented since 2019 spanning on 7 stocks. Analyst's average stock valuation to be materialised ratio is 23.7% with an average time for price targets to be met of 91.57 days.

Most recent stock forecast was given on PRVB, Provention Bio, Inc at 18-Nov-2022.

Justin Kim best performing recommendations are on AUPH (AURINIA PHARMACEUTICALS INC).
The best stock recommendation documented was for AUPH (AURINIA PHARMACEUTICALS INC) at 10/28/2021. The price target of $32 was fulfilled within 1 day with a profit of $2.04 (6.81%) receiving and performance score of 68.09.

Average potential price target upside

ANGN APLS AUPH BCRX CYTK PRVB PHVS
ANGN APLS AUPH BCRX CYTK PRVB PHVS